Zhejiang NHU Company (002001) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
27 Oct, 2026Executive summary
Q3 2026 revenue was RMB 6.102bn, up 10.12% YoY; net profit attributable to shareholders was RMB 1.857bn, up 8.13%.
Q1–Q3 revenue reached RMB 19.231bn, up 15.56% YoY; attributable net profit was RMB 5.868bn, up 10.28%.
Financial highlights
Q3 adjusted net profit, excluding non-recurring gains and losses, was RMB 1.797bn, up 8.59% YoY; basic EPS was RMB 0.60, up 7.14%.
Q1–Q3 adjusted net profit was RMB 5.716bn, up 7.17% YoY; basic EPS was RMB 1.90, up 9.83%.
Q1–Q3 operating profit was RMB 6.894bn versus RMB 6.252bn in 2025; net profit was RMB 5.896bn versus RMB 5.354bn.
Q1–Q3 non-recurring gains and losses totaled RMB 152.2m, including RMB 153.1m from fair-value changes and trading financial asset disposals.
Key financial ratios and metrics
Weighted average ROE was 5.33% for Q3, down 0.12 percentage points YoY; Q1–Q3 ROE was 16.72%, down 0.60 percentage points.
At September 30, 2026, total assets were RMB 49.259bn, up 8.01% from year-end 2025; attributable net assets were RMB 36.549bn, up 11.41%.
Latest events from Zhejiang NHU Company
- Net profit surged 15.26% to RMB 6.76 billion on steady revenue and strong global expansion.002001
Q4 2025 - Revenue up 18.28% YoY and net profit up 11.31%, led by nutrition segment growth.002001
Q2 2026 - Revenue up 15.72% year-over-year, but net profit fell 2.80% due to rising costs.002001
Q1 2026 - Net profit jumped 33% year-over-year on higher revenue and strong capital actions.002001
Q3 2025 - Net profit jumped 63.46% YoY on strong sales, margin gains, and capital returns.002001
Q2 2025 - Q3 net profit soared 189% year-over-year, with major expansion into nylon materials approved.002001
Q3 2024 - Net profit jumped 48.6% on 32.7% revenue growth, led by nutrition and vitamin sales.002001
Q2 2024 - Net profit more than doubled on strong revenue growth and margin expansion in 2024.002001
Q4 2024 - Net profit more than doubled year-over-year in Q1 2025, driven by robust revenue and investment gains.002001
Q1 2025